CRE Superbug Outbreak at UCLA Ronald Regan Medical Center Legal News Articles & Interviews

Santa Monica, CA: A damning exposé on endoscopes that appeared earlier this month in the Los Angeles Times (12/19/15) provides a troubling backdrop to a rash of serious infections and responses undertaken by a manufacturer that commands the single largest sector of the endoscopy market in the United States. Such revelations would be of interest to any plaintiff fighting an Endoscopy lawsuit, of which there are several.

Las Vegas, NV In February 2015, officials at UCLA Ronald Reagan Medical Center reported that seven patients at the hospital were infected and two died after being infected with a deadly superbug embedded in a type of medical device known as a duodenoscope (or ERCP endoscope) used to investigate patients with gastrointestinal complaints.

Washington, DC In a telling statement as to the effectiveness of medical device oversight and adherence (or lack thereof) to long-held guidelines and approval tenets, the manufacturer of a product used in duodenoscopy managed to vend its device to the medical community for more than three years before anyone realized the device did not carry proper clearance by the US Food and Drug Administration (FDA). The resulting CRE Superbug Outbreak at UCLA Ronald Reagan Medical Center (RRMC) made seven patients seriously ill. Two died.

Los Angeles, CA Two people are dead and 179 potentially infected with a deadly superbug found at a UCLA medical center. According to a report by Frontline, the antibiotic resistant superbug outbreak took place at Ronald Reagan Medical Center from October 2014 to January 2015.